↓ Skip to main content

GLP-1 Receptor Agonists and Coronary Arteries: From Mechanisms to Events

Overview of attention for article published in Frontiers in Pharmacology, March 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
2 news outlets
twitter
4 X users

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
GLP-1 Receptor Agonists and Coronary Arteries: From Mechanisms to Events
Published in
Frontiers in Pharmacology, March 2022
DOI 10.3389/fphar.2022.856111
Pubmed ID
Authors

Aurélie Pahud de Mortanges, Eldem Sinaci, Dante Salvador, Lia Bally, Taulant Muka, Matthias Wilhelm, Arjola Bano

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 12%
Unspecified 2 8%
Student > Bachelor 1 4%
Student > Doctoral Student 1 4%
Student > Ph. D. Student 1 4%
Other 1 4%
Unknown 16 64%
Readers by discipline Count As %
Medicine and Dentistry 5 20%
Unspecified 2 8%
Biochemistry, Genetics and Molecular Biology 2 8%
Engineering 1 4%
Unknown 15 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 January 2024.
All research outputs
#2,438,766
of 26,230,991 outputs
Outputs from Frontiers in Pharmacology
#1,050
of 20,176 outputs
Outputs of similar age
#56,487
of 453,484 outputs
Outputs of similar age from Frontiers in Pharmacology
#58
of 1,245 outputs
Altmetric has tracked 26,230,991 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,176 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 453,484 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 1,245 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.